Abstract
The hair loss in 8 cancer patients aged between 18 and 60 years on chemotherapy was studied. All had diffuce moderate alopecio within 1 month of starting treatment. Of the 8, 3 had only telogen hairs and 3 had high dystrophic hair count. Both anagen and telogen effluvium are implicated.
| Original language | English |
|---|---|
| Pages (from-to) | 131-132 |
| Number of pages | 2 |
| Journal | Indian Journal of Dermatology, Venereology and Leprology |
| Volume | 69 |
| Issue number | 2 |
| Publication status | Published - 01-03-2003 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Dermatology
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Hair loss in cancer chemotherapeutic patients'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver